HDAC3 increases HMGB3 expression to facilitate the immune escape of breast cancer cells via down-regulating microRNA-130a-3p
- PMID: 33727043
- DOI: 10.1016/j.biocel.2021.105967
HDAC3 increases HMGB3 expression to facilitate the immune escape of breast cancer cells via down-regulating microRNA-130a-3p
Retraction in
-
Retraction notice to "HDAC3 increases HMGB3 expression to facilitate the immune escape of breast cancer cells via down-regulating microRNA-130a-3p" [Int. J. Biochem. Cell Biol. 135 (2021) 105967].Int J Biochem Cell Biol. 2024 Sep;174:106620. doi: 10.1016/j.biocel.2024.106620. Epub 2024 Jul 16. Int J Biochem Cell Biol. 2024. PMID: 39019716 No abstract available.
Abstract
Objective: Histone deacetylase 3 (HDAC3) has been reported to repress the expression of various genes by eliminating acetyl group from histone. The objective of this study was to discuss the effect of HDAC3/microRNA-130a-3p (miR-130a-3p)/high-mobility group box 3 (HMGB3) on immune escape of breast cancer.
Methods: HDAC3, miR-130a-3p and HMGB3 expression in breast cancer tissues and cells were tested, and the correlation between HDAC3, miR-130a-3p and HMGB3 was analyzed. CD8, CD69 and programmed cell death protein 1 (PD-1) expression was detected. MDA-MB-231 cells were treated with relative plasmid of HDAC3 or miR-130a-3p to test cell viability, migration, epithelial-mesenchymal transition (EMT) and apoptosis in MDA-MB-231 cells. The cytotoxicity of CD8+/CD69+/PD-1+T cells in MDA-MB-231 cells was tested, and CD8+/CD69+/PD-1+T cell proliferation and apoptosis before and after co-culture with MDA-MB-231 cells were detected.
Results: HDAC3 and HMGB3 expression were raised and miR-130a-3p expression was diminished in breast cancer tissues and cells. HDAC3 was negatively correlated with miR-130a-3p while miR-130a-3p was negatively correlated with HMGB3. Down-regulating HDAC3 or up-regulating miR-130a-3p restrained cell viability, migration, EMT and anti-CD8+/CD69+/PD-1+T cytotoxicity and facilitated apoptosis of breast cancer cells. HDAC3 regulated HMGB3 by mediating miR-130a-3p expression. Down-regulating miR-130a-3p reversed the role of HDAC3 reduction on breast cancer cells. HDAC3 regulated CD8+/CD69+/PD-1+T cell proliferation and apoptosis by mediating miR-130a-3p.
Conclusion: This study provides evidence that HDAC3 increases HMGB3 expression to promote the immune escape of breast cancer cells via down-regulating miR-130a-3p.
Keywords: Apoptosis; Breast cancer; High-mobility group box 3; Histone deacetylases 3; Immune escape; MicroRNA-130a-3p.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Similar articles
-
Down-regulated HDAC3 elevates microRNA-495-3p to restrain epithelial-mesenchymal transition and oncogenicity of melanoma cells via reducing TRAF5.J Cell Mol Med. 2020 Nov;24(22):12933-12944. doi: 10.1111/jcmm.15885. Epub 2020 Oct 13. J Cell Mol Med. 2020. PMID: 33048450 Free PMC article.
-
HMGB3 inhibition by miR-142-3p/sh-RNA modulates autophagy and induces apoptosis via ROS accumulation and mitochondrial dysfunction and reduces the tumorigenic potential of human breast cancer cells.Life Sci. 2022 Sep 1;304:120727. doi: 10.1016/j.lfs.2022.120727. Epub 2022 Jun 23. Life Sci. 2022. PMID: 35753437
-
Tumor suppressive function of mir-205 in breast cancer is linked to HMGB3 regulation.PLoS One. 2013 Oct 2;8(10):e76402. doi: 10.1371/journal.pone.0076402. eCollection 2013. PLoS One. 2013. PMID: 24098490 Free PMC article.
-
CircMMP1 promotes the progression of glioma through miR-433/HMGB3 axis in vitro and in vivo.IUBMB Life. 2020 Nov;72(11):2508-2524. doi: 10.1002/iub.2383. Epub 2020 Sep 12. IUBMB Life. 2020. PMID: 32918539
-
Overview of high mobility group box 3 (HMGB3] protein.Mol Genet Genomics. 2025 Jun 11;300(1):59. doi: 10.1007/s00438-025-02266-2. Mol Genet Genomics. 2025. PMID: 40498374 Review.
Cited by
-
Enterotoxigenic Bacteroides fragilis (ETBF) Enhances Colorectal Cancer Cell Proliferation and Metastasis Through HDAC3/miR-139-3p Pathway.Biochem Genet. 2024 Oct;62(5):3904-3919. doi: 10.1007/s10528-023-10621-4. Epub 2024 Jan 20. Biochem Genet. 2024. PMID: 38244157
-
Roles of HMGBs in Prognosis and Immunotherapy: A Pan-Cancer Analysis.Front Genet. 2021 Oct 29;12:764245. doi: 10.3389/fgene.2021.764245. eCollection 2021. Front Genet. 2021. PMID: 34777483 Free PMC article.
-
Structure and Functions of HMGB3 Protein.Int J Mol Sci. 2024 Jul 12;25(14):7656. doi: 10.3390/ijms25147656. Int J Mol Sci. 2024. PMID: 39062899 Free PMC article. Review.
-
Overexpression of HMGB3 and its prognostic value in breast cancer.Front Oncol. 2022 Dec 22;12:1048921. doi: 10.3389/fonc.2022.1048921. eCollection 2022. Front Oncol. 2022. PMID: 36620553 Free PMC article.
-
HDAC inhibitor ITF2357 reduces resistance of mutant-KRAS non-small cell lung cancer to pemetrexed through a HDAC2/miR-130a-3p-dependent mechanism.J Transl Med. 2023 Feb 15;21(1):125. doi: 10.1186/s12967-023-03973-3. J Transl Med. 2023. PMID: 36793108 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous